Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMVAMUNE Prophylaxis for Vaccinia Virus Workers
NCT03472014Phase 4Completed
- Sponsor
- Bavarian Nordic
- Start
- Apr 2010
- Primary completion
- Nov 2014
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of JYNNEOS in smallpox, sponsored by Bavarian Nordic. Started Apr 2010; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT03472014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472014.